Here’s Who Just Picked Up Helios and Matheson Analytics Inc. (NASDAQ:HMNY) Shares

In a just published Form 13, filed with the US Securities and Exchange Commission (SEC), Helios and Matheson Analytics Inc. (NASDAQ:HMNY) reported that Farnsworth Theodore has picked up 1,990,000 of common stock as of 2017-01-26.

The acquisition brings the aggregate amount owned by Farnsworth Theodore to a total of 1,990,000 representing a 31.48% stake in the company.

For those not familiar with the company, Helios and Matheson Analytics Inc. is an information technology services company. The Company offers its clients a suite of services of predictive analytics with technology. The Company provides offerings in the areas of application value management, application development, integration, independent validation, infrastructure and information management, and analytics services. The Company offers an integrated service of Big Data technology, analytics, domain knowledge in the areas of financial services and healthcare, including data visualization. The Company’s clients operate in a range of industries with a concentration in the banking, financial services, insurance and healthcare industries.

A glance at Helios and Matheson Analytics Inc. (NASDAQ:HMNY)’s key stats reveals a current market capitalization of  15.60 million based on 4.87 million shares outstanding and a price at last close of $3.59 per share.

Looking at insider activity, there are a few transactions worth noting.

Specifically, on 2012-01-11, Helios picked up 230,000 at a purchase price of $2.00. This brings their total holding to 1,973,040 as of the date of the filing.

On the sell side, the most recent transaction saw Helios unload 230,000 shares at a sale price of $2.00. This brings their total holding to 1,743,040.

It’s possible to gauge a company’s potential by tracking the activity of its major holders, as well as checking in on insider activity such as those transactions listed above. We’ll be keeping an eye on Helios and Matheson Analytics Inc. (NASDAQ:HMNY) as things move forward to see if its progress aligns with these transactions.

Subscribe below and we’ll keep you on top of what’s happening before it moves markets.

 

 

 

Author: Richard Schwarz

Richard Schwarz is a veteran analyst in the small cap space, with a particular focus on the development stage biotech sector. He is a native of Canada, and attended NYU before working for a host of big name pharma outfits.

Share This Post On

Submit a Comment

Your email address will not be published. Required fields are marked *